In the last decade, experiments have shown that cancer cells, instead of performing full EMT, perform partial EMT (pEMT) by gaining mesenchymal properties, particularly by preserving epithelial markers such as E-cadherin [41]. This evidence concerns the gene CDH1 and cancer.